Tullo A - Search Results

1

ZD1839, a selective oral epidermal growth factor receptor-tyrosine kinase inhibitor, is well tolerated and active in patients with solid, malignant tumors: results of a phase I trial.

Ranson M, Hammond LA, Ferry D, Kris M, Tullo A, Murray PI, Miller V, Averbuch S, Ochs J, Morris C, Feyereislova A, Swaisland H, Rowinsky EK. Ranson M, et al. Among authors: tullo a. J Clin Oncol. 2002 May 1;20(9):2240-50. doi: 10.1200/JCO.2002.10.112. J Clin Oncol. 2002. PMID: 11980995 Clinical Trial.

2

Ocular findings in patients with solid tumours treated with the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib ('Iressa', ZD1839) in Phase I and II clinical trials.

Tullo AB, Esmaeli B, Murray PI, Bristow E, Forsythe BJ, Faulkner K. Tullo AB, et al. Eye (Lond). 2005 Jul;19(7):729-38. doi: 10.1038/sj.eye.6701630. Eye (Lond). 2005. PMID: 15688060 Clinical Trial.

3

Comparison of topical and oral acyclovir in early herpes zoster ophthalmicus.

Neoh C, Harding SP, Saunders D, Wallis S, Tullo AB, Nylander A, Nelson ME. Neoh C, et al. Among authors: tullo ab. Eye (Lond). 1994;8 ( Pt 6):688-91. doi: 10.1038/eye.1994.170. Eye (Lond). 1994. PMID: 7867830 Clinical Trial.

4

The effects of growth factors and conditioned media on the proliferation of human corneal epithelial cells and keratocytes.

Pancholi S, Tullo A, Khaliq A, Foreman D, Boulton M. Pancholi S, et al. Among authors: tullo a. Graefes Arch Clin Exp Ophthalmol. 1998 Jan;236(1):1-8. doi: 10.1007/s004170050034. Graefes Arch Clin Exp Ophthalmol. 1998. PMID: 9457509

5

Canalicular infection caused by Actinomyces.

Hussain I, Bonshek RE, Loudon K, Armstrong M, Tullo AB. Hussain I, et al. Among authors: tullo ab. Eye (Lond). 1993;7 ( Pt 4):542-4. doi: 10.1038/eye.1993.118. Eye (Lond). 1993. PMID: 8253235

6

Ocular surface disease in intensive care unit patients.

Mercieca F, Suresh P, Morton A, Tullo A. Mercieca F, et al. Among authors: tullo a. Eye (Lond). 1999 Apr;13 ( Pt 2):231-6. doi: 10.1038/eye.1999.57. Eye (Lond). 1999. PMID: 10450388

7

Management of day-surgery patients with cataract attending a peripheral ophthalmic clinic.

Rose K, Waterman H, Toon L, McLeod D, Tullo A. Rose K, et al. Among authors: tullo a. Eye (Lond). 1999;13 ( Pt 1):71-5. doi: 10.1038/eye.1999.14. Eye (Lond). 1999. PMID: 10396388 Clinical Trial.

8

Increased Rac2 mRNA expression in peripheral blood during human corneal graft rejection.

Huang MC, Tullo AB, Hillarby MC. Huang MC, et al. Among authors: tullo ab. Eye (Lond). 2009 Feb;23(2):461-9. doi: 10.1038/eye.2008.306. Epub 2008 Oct 10. Eye (Lond). 2009. PMID: 18849916

9

A comparison of clinical performance between disposable and Goldmann tonometers.

Maino AP, Uddin HJ, Tullo AB. Maino AP, et al. Among authors: tullo ab. Eye (Lond). 2006 May;20(5):574-8. doi: 10.1038/sj.eye.6701929. Eye (Lond). 2006. PMID: 15920568

10

Corneal autoimmunity in patients with peripheral ulcerative keratitis (PUK) in association with rheumatoid arthritis and Wegener's granulomatosis.

John SL, Morgan K, Tullo AB, Holt PJ. John SL, et al. Among authors: tullo ab. Eye (Lond). 1992;6 ( Pt 6):630-6. doi: 10.1038/eye.1992.136. Eye (Lond). 1992. PMID: 1289143

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

214 results

Search Page

Filters